5-Month Multicomponent Exercise Program Targets Brain and Cognition in MCI-Risk Adults
A randomized trial tests whether supervised aerobic, strength, and cognitive exercise can protect the aging brain in adults at risk for Alzheimer's.
Summary
This completed randomized controlled trial from the University of Cadiz enrolled 100 adults aged 65–75 who were at risk for mild cognitive impairment (MCI). Half completed a five-month supervised multicomponent exercise program combining aerobic, strength, cognitive, and balance training, while the other half served as controls. The trial measured changes in brain structure and function via neuroimaging, cognitive performance, OMICS markers (genomics, proteomics, metabolomics), antioxidant capacity, lipid and glucose metabolism, blood pressure, body composition, and quality of life. A follow-up retest was conducted three months after the intervention ended, allowing researchers to assess durability of any gains. The study aims to clarify the dose-response relationship between structured exercise and brain health from a multidimensional perspective, offering potential insights into exercise as a non-pharmacological strategy to delay Alzheimer's onset.
Detailed Summary
Mild cognitive impairment represents a critical window for intervention — the period between normal aging and dementia where lifestyle changes may meaningfully alter trajectory. Exercise is one of the most promising non-pharmacological tools available, yet the precise mechanisms by which it protects the aging brain remain poorly understood. This trial was designed to close that gap with rigorous, multidimensional measurement.
Researchers at the University of Cadiz recruited 100 adults between ages 65 and 75 who were identified as being at risk for MCI. Participants were randomly assigned to either a five-month supervised exercise program or a control group (n=50 each). The exercise protocol was multicomponent, incorporating aerobic conditioning, resistance training, cognitive challenges, and coordinative-agility-balance work, with progressive increases in frequency, volume, intensity, and density over time.
The breadth of outcomes assessed is a standout feature. Primary endpoints included neuroimaging measures of brain structure and function, cognitive performance, and OMICS markers — spanning genomics, proteomics, and metabolomics. Secondary endpoints covered antioxidant capacity, lipid and glucose metabolism, physical functional capacity, blood pressure, body composition, depression, and quality of life. A third measurement point three months post-intervention assessed whether benefits persisted after structured exercise ceased.
This comprehensive framework allows investigators to examine not just whether exercise works, but how — tracing molecular and genomic signatures that may explain cognitive protection. Understanding these pathways could help identify who benefits most and optimize exercise prescriptions for brain health in aging populations.
Caveats are notable. The trial is now completed but published results are not yet widely available in peer-reviewed literature based on this abstract alone. The sample size of 100, while adequate for primary endpoints, may limit subgroup analyses. Generalizability to adults outside the 65–75 age window or with established MCI remains uncertain. This summary is based on the abstract only.
Key Findings
- 5-month multicomponent exercise targeting aerobic, strength, cognitive, and balance domains was tested in MCI-risk adults aged 65–75.
- OMICS profiling (genomic, proteomic, metabolomic) was included to uncover molecular mechanisms behind exercise-driven brain protection.
- Neuroimaging paired with cognitive testing aimed to capture structural and functional brain changes from exercise.
- A 3-month post-intervention retest assessed whether cognitive and biological benefits persisted after the program ended.
- Secondary outcomes included Alzheimer's risk biomarkers, antioxidant capacity, glucose and lipid metabolism, and quality of life.
Methodology
Randomized controlled trial with 100 adults (aged 65–75) at risk for MCI, split evenly into exercise intervention and control groups. The 5-month supervised multicomponent program included progressive loading across aerobic, strength, cognitive, and balance modalities, with assessments at baseline, post-intervention, and 3-month follow-up. Outcomes spanned neuroimaging, cognitive testing, OMICS panels, and metabolic and psychological measures.
Study Limitations
This summary is based on the abstract only, as the full trial results are not available from this record. The sample size of 100 may be underpowered for subgroup or OMICS-level analyses. Results may not generalize beyond adults aged 65–75 with MCI risk and without established dementia.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: